These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12682671)
1. Molecule of the month. Memantine hydrochloride. Drug News Perspect; 2003; 16(1):55. PubMed ID: 12682671 [No Abstract] [Full Text] [Related]
2. Memantine (Namenda, Forest Pharmaceuticals). Roman MW Issues Ment Health Nurs; 2009 Mar; 30(3):202. PubMed ID: 19291500 [No Abstract] [Full Text] [Related]
3. FDA approves memantine drug for treating AD. Am J Alzheimers Dis Other Demen; 2003; 18(6):329-30. PubMed ID: 14682078 [No Abstract] [Full Text] [Related]
5. Memantine: the next trend in academic performance enhancement? Ota KS; Godwin T J Am Osteopath Assoc; 2006 Jun; 106(6):358-9. PubMed ID: 16790543 [No Abstract] [Full Text] [Related]
6. [Little behavior improvement with memantine]. Potz-Biedermann C Med Monatsschr Pharm; 2005 Nov; 28(11):413-4. PubMed ID: 16309030 [No Abstract] [Full Text] [Related]
7. Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease. Rabins PV; Lyketsos CG Nat Clin Pract Neurol; 2006 Nov; 2(11):578-9. PubMed ID: 17057739 [No Abstract] [Full Text] [Related]
8. Memantine (Namenda) for moderate to severe Alzheimer's disease. Ables AZ Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415 [No Abstract] [Full Text] [Related]
9. [New options for the pharmacotherapy of Alzheimer disease after the approval of memantine? Re the article from DMW 8/2005]. Wellhöfer B Dtsch Med Wochenschr; 2006 Feb; 131(6):284. PubMed ID: 16463237 [No Abstract] [Full Text] [Related]
11. Drug for moderate to advanced Alzheimer's approved. Mayo Clin Health Lett; 2004 Feb; 22(2):4. PubMed ID: 15032170 [No Abstract] [Full Text] [Related]